The US FDA is not expecting a decrease in ANDA receipts in fiscal years 2019 and 2020, even though its budget request suggests that a drop will happen.
The agency wrote in its FY 2020 budget request congressional justification that after receiving 1,044 ANDAs in FY 2018, the agency expected to receive only 1,000 in FY 2019...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?